阿比特龙 T6216

Product Introduction
Bioactivity


英文名: Abiraterone

描述: Abiraterone (CB-7598) 是不可逆的CYP17A1抑制剂，具有抗雄激素作用，抑制细胞色素 p450 酶 CYP17 的 17α-羟化酶 (IC50:2.5 nM) 和 17,20-裂合酶 (IC50:15 nM) 活性。

细胞实验: LNCaP and VCaP cells are seeded in 96-well plates and grown in CSS-supplemented phenol red-free or FBS-supplemented media for 7 days. Cells are treated with Abiraterone at 24 hours and 96 hours after plating and cell viability is determined on day 7 by adding CellTiter Glo and measuring luminescence.(Only for Reference)

激酶实验: C17,20-lyase activity assay: Microsomes are diluted to a final protein concentration of 50 μg/mL in the reaction mixture which contained 0.25 M sucrose, 20 mM Tris–HCl (pH 7.4), 10 mM G6P and 1.2 IU/mL G6PDH. After equilibration at 37 °C for 10 minutes, the reaction is initiated by addition of βNADP to obtain a final concentration of 0.6 mM. Prior to the distribution of 600 μL of the reaction mixture in each tube, Abiraterone is evaporated to dryness under a stream of nitrogen and then are incubated at 37 °C for 10 minutes. After incubation with Abiraterone, 500 μL of the reaction mixture is transferred to tubes containing 1 μM of the enzyme substrate, 17OHP. After a further 10 minutes incubation, tubes are placed on ice and the reaction is stopped by addition of 0.1 ml NaOH 1N. Tubes are deep-frozen and stored at ?20 °C until assayed for Δ4A levels. A Δ4A RIA is developed and automated on a microplate format using a specific antibody against Δ4A. The separation of free and bound antigen is achieved with a dextran-coated charcoal suspension. After centrifugation, aliquots of the clear supernatant are counted in duplicates in a 1450 MicrobetaPlus liquid scintillation counter. The Δ4A concentrations of unknown samples are determined from the standard curve. The detection limit is 0.5 ng/mL and the within and between assay coefficients of variation are 10.7 and 17.6%, respectively at an assay value of 13 ng/mL. The rate of enzymatic reaction is expressed as pmol of Δ4A formed per 10 minutes and per mg of protein. The value of maximum activity without inhibitor (control) is set at 100%. The IC50 values are calculated using non-linear analysis from the plot of enzyme activity (%) against log of inhibitor concentration.

体外活性: Abiraterone对睾丸激素水平的降低效果几乎切除睾丸的效果相同.Abiraterone对任何器官尺寸均无明显降低作用.Abiraterone可抑制人类睾丸微粒体中CYP17（IC50：72 nM）.与对照组相比,Abiraterone 降低 95%以上睾丸激素水平.

体内活性: Abiraterone抑制体外增殖和雄激素受体调节的雄激素受体阳性前列腺癌细胞基因表达,这可能是通过抑制类固醇和抗雄激素受体实现的。更高浓度的Abiraterone抑制依普利酮激活的突变型雄激素受体。Abiraterone 取代WT-AR（EC50：13.4 μM）和T877A（EC50：7.9 μM）中的配体。Abiraterone醋酸盐明显抑制T分泌（48%）,且可使LH浓度达到192%。Abiraterone抑制大鼠睾丸微粒的裂解酶活性（IC50：5.8 nM）。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : 5.4 mg/mL (15.45 mM)
DMF : 8.75 mg/mL (25.04 mM)
DMSO : 1mg/ml


关键字: Inhibitor | Cytochrome P450 | CB 7598 | inhibit | CYPs | CB7598 | Abiraterone

相关产品: Topiroxostat | Albaconazole | Rutacridone | Retrorsine | (±)-N-3-Benzylnirvanol | Danshensu sodium salt | Isavuconazole | α-​Terpinyl acetate | Cephaeline dihydrochloride | Atovaquone

相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | Drug-induced Liver Injury (DILI) Compound Library | Anti-Cancer Drug Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Approved Drug Library | EMA Approved Drug Library | Metabolism Compound Library

阿比特龙 T6216信息由TargetMol中国为您提供，如您想了解更多关于阿比特龙 T6216报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途